Financial Ratios IRLAB Therapeutics AB

Stocks

IRLAB A

SE0012675361

Pharmaceuticals

Delayed Nasdaq Stockholm Other stock markets 07:55:29 09/06/2026 pm IST			5-day change	1st Jan Change
1.208 ^SEK	-2.58%		-1.79%	-38.68%

08/06	Irlab shares trade ex-rights on Nasdaq Stockholm following rights issue	FW
06/06	IRLAB Therapeutics AB Announces Board Elections, Effective June 5, 2026	CI

bda7877604f6b992209e15f69433c0.3ZefAJECXVbjBnsE-yBI6WZLccQ8praQ2-WH3xnE83A.heH0edNULAeuNCNnkmkRjycjQaMFnuPE46Lk8mOSpQaF2qdVxC8KBqQyPg

Published financial data: IRLAB THERAPEUTICS AB

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	-	21Cr	6.11Cr	56.78L	9.46Cr
Other Revenues, Total	3L	-	-	-	-
Total Revenues	3L	21Cr	6.11Cr	56.78L	9.46Cr
Cost of Goods Sold, Total	6.56Cr	8.17Cr	13Cr	13Cr	14Cr
Gross Profit	-6.53Cr	13Cr	-6.48Cr	-12Cr	-4.17Cr
Selling General & Admin Expenses, Total	2.4Cr	3.1Cr	4.25Cr	5.31Cr	4.62Cr
Depreciation & Amortization - (IS)	22.56L	34.74L	47.79L	43.16L	45.83L
Other Operating Expenses	-96T	3.9Cr	-27T	-42T	-1.95Cr
Other Operating Expenses, Total	2.61Cr	7.35Cr	4.72Cr	5.74Cr	3.13Cr
Operating Income	-9.15Cr	5.26Cr	-11Cr	-18Cr	-7.3Cr
Interest Expense, Total	-2L	-4L	-3L	-2L	-1.05Cr
Interest And Investment Income	1T	1T	-	31.25L	24.59L
Net Interest Expenses	-2L	-4L	-3L	29.26L	-80.18L
Currency Exchange Gains (Loss)	-	-4L	-11.06L	-7L	-21.43L
Other Non Operating Income (Expenses)	-1T	-	-	1T	-
EBT, Excl. Unusual Items	-9.17Cr	5.18Cr	-11Cr	-18Cr	-8.31Cr
Asset Writedown	-	-	-	-	-
Insurance Settlements	-	-	-	-	-
EBT, Incl. Unusual Items	-9.17Cr	5.18Cr	-11Cr	-18Cr	-8.31Cr
Income Tax Expense	-	-	-	-	-
Earnings From Continuing Operations	-9.17Cr	5.18Cr	-11Cr	-18Cr	-8.31Cr
Net Income to Company	-9.17Cr	5.18Cr	-11Cr	-18Cr	-8.31Cr
Minority Interest	-	-	-	-	-
Net Income - (IS)	-9.17Cr	5.18Cr	-11Cr	-18Cr	-8.31Cr
Net Income to Common Incl Extra Items	-9.17Cr	5.18Cr	-11Cr	-18Cr	-8.31Cr
Net Income to Common Excl. Extra Items	-9.17Cr	5.18Cr	-11Cr	-18Cr	-8.31Cr
Per Share Items
Net EPS - Basic	-1.92	1	-2.19	-3.43	-1.6
Basic EPS - Continuing Operations	-1.92	1	-2.19	-3.43	-1.6
Basic Weighted Average Shares Outstanding	4.77Cr	5.17Cr	5.18Cr	5.19Cr	5.19Cr
Net EPS - Diluted	-1.92	1	-2.19	-3.43	-1.6
Diluted EPS - Continuing Operations	-1.92	1	-2.19	-3.43	-1.6
Diluted Weighted Average Shares Outstanding	4.77Cr	5.17Cr	5.18Cr	5.19Cr	5.19Cr
Normalized Basic EPS	-1.2	0.63	-1.37	-2.14	-1
Normalized Diluted EPS	-1.2	0.63	-1.37	-2.14	-1
Supplemental Items
EBITDA	-9.11Cr	5.31Cr	-11Cr	-18Cr	-7.21Cr
EBITA	-9.15Cr	5.26Cr	-11Cr	-18Cr	-7.3Cr
EBIT	-9.15Cr	5.26Cr	-11Cr	-18Cr	-7.3Cr
EBITDAR	-9.1Cr	5.33Cr	-	-	-
Total Revenues (As Reported)	4L	21Cr	6.13Cr	57.2L	11Cr
Effective Tax Rate - (Ratio)	-	-	-	-	-
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	-5.73Cr	3.24Cr	-7.09Cr	-11Cr	-5.2Cr
Interest on Long-Term Debt	2L	4L	-	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	7.6Cr	13Cr	15Cr	15Cr	16Cr
Net Rental Expense, Total	1L	2L	-	-	-
Imputed Operating Lease Interest Expense	54.3T	1L	-	-	-
Imputed Operating Lease Depreciation	75.7T	70.8T	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	28Cr	40Cr	25Cr	11Cr	6.69Cr
Total Cash And Short Term Investments	28Cr	40Cr	25Cr	11Cr	6.69Cr
Accounts Receivable, Total	-	44.7L	33.22L	-	-
Other Receivables	47.11L	62.74L	88.96L	91.67L	1.01Cr
Total Receivables	47.11L	1.07Cr	1.22Cr	91.67L	1.01Cr
Prepaid Expenses	20.2L	22.79L	33.44L	27.97L	21.97L
Other Current Assets, Total	1T	65.2L	3L	3L	4L
Total Current Assets	28Cr	42Cr	27Cr	12Cr	7.96Cr
Gross Property Plant And Equipment	96.02L	1.67Cr	2.01Cr	2.31Cr	3.08Cr
Accumulated Depreciation	-52.85L	-83.57L	-1.21Cr	-1.64Cr	-2.1Cr
Net Property Plant And Equipment	43.17L	83.49L	80.1L	66.72L	97.93L
Other Intangibles, Total	8.15Cr	4.24Cr	4.69Cr	4.69Cr	4.69Cr
Deferred Charges Long-Term	5L	3L	-	-	-
Other Long-Term Assets, Total	-	-1T	-1T	-	-1T
Total Assets	37Cr	47Cr	32Cr	18Cr	14Cr
Liabilities
Accounts Payable, Total	36.83L	1.23Cr	1Cr	1.05Cr	99.4L
Accrued Expenses, Total	1.18Cr	58.44L	1.34Cr	1.49Cr	1.17Cr
Short-term Borrowings	-	-	-	-	5.35Cr
Current Portion of Leases	16.57L	30.34L	35.95L	29.4L	34.19L
Unearned Revenue Current, Total	-	4.26Cr	-	-	-
Other Current Liabilities	37.73L	56.46L	52.82L	83.54L	2.15Cr
Total Current Liabilities	2.09Cr	6.94Cr	3.23Cr	3.67Cr	10Cr
Long-Term Debt	-	-	-	2.45Cr	-
Long-Term Leases	12.7L	35.66L	4L	1L	35.36L
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	2.22Cr	7.3Cr	3.27Cr	6.14Cr	10Cr
Common Stock, Total	10L	10.35L	10.37L	10.37L	10.37L
Additional Paid In Capital	69Cr	69Cr	69Cr	69Cr	69Cr
Retained Earnings	-34Cr	-29Cr	-40Cr	-58Cr	-66Cr
Comprehensive Income and Other	66T	-	-	-	1T
Total Common Equity	35Cr	40Cr	29Cr	12Cr	3.26Cr
Total Equity	35Cr	40Cr	29Cr	12Cr	3.26Cr
Total Liabilities And Equity	37Cr	47Cr	32Cr	18Cr	14Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	5.17Cr	5.17Cr	5.19Cr	5.19Cr	5.19Cr
ECS Total Common Shares Outstanding	5.17Cr	5.17Cr	-	5.19Cr	5.19Cr
Book Value / Share	6.72	7.72	5.61	2.23	0.63
Tangible Book Value	27Cr	36Cr	24Cr	6.89Cr	-1.42Cr
Tangible Book Value Per Share	5.15	6.9	4.7	1.33	-0.27
Total Debt	29.27L	66L	39.76L	2.76Cr	6.04Cr
Net Debt	-27Cr	-40Cr	-25Cr	-8.37Cr	-64.96L
Debt Equivalent Oper. Leases	10.4L	14.96L	-	-	-
Account Code - Inventory Valuation	3	3	-	3	3
Machinery, Total	29.42L	36.5L	65.27L	68.21L	70.21L
Full Time Employees	20	27	-	34	31

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-9.17Cr	5.18Cr	-11Cr	-18Cr	-8.31Cr
Depreciation & Amortization - CF	19.97L	32.15L	37.23L	43.16L	45.83L
Depreciation & Amortization, Total	19.97L	32.15L	37.23L	43.16L	45.83L
Amortization of Deferred Charges, Total - (CF)	3L	3L	3L	-	-
Asset Writedown & Restructuring Costs	-	-	8L	-	-
Other Operating Activities, Total	0	3.91Cr	0	0	39.55L
Change In Accounts Receivable	26.2L	-1.28Cr	36.34L	36.3L	27.92L
Change in Other Net Operating Assets	-24.37L	4.71Cr	-3.76Cr	50.43L	62.09L
Cash from Operations	-8.92Cr	13Cr	-14Cr	-16Cr	-6.56Cr
Capital Expenditure	-4L	-7L	-28.76L	-3L	-2L
Sale (Purchase) of Intangible assets	-	-	-5L	-	-
Cash from Investing	-4L	-7L	-33.76L	-3L	-2L
Long-Term Debt Issued, Total	-	-	-	2.73Cr	2.5Cr
Total Debt Issued	-	-	-	2.73Cr	2.5Cr
Long-Term Debt Repaid, Total	-16.16L	-28.65L	-31.34L	-36.06L	-36.04L
Total Debt Repaid	-16.16L	-28.65L	-31.34L	-36.06L	-36.04L
Issuance of Common Stock	28Cr	-	-	-	-
Other Financing Activities, Total	-1.78Cr	-2L	-	-	-
Cash from Financing	26Cr	-30.45L	-31.34L	2.37Cr	2.14Cr
Miscellaneous Cash Flow Adjustments	-1T	-	1T	-	1T
Net Change in Cash	17Cr	12Cr	-15Cr	-14Cr	-4.44Cr
Supplemental Items
Cash Interest Paid	2L	8L	3L	2L	65.22L
Levered Free Cash Flow	-5.52Cr	6.97Cr	-10Cr	-10Cr	-3.88Cr
Unlevered Free Cash Flow	-5.51Cr	6.99Cr	-10Cr	-9.99Cr	-3.22Cr
Change In Net Working Capital	-2L	-3.43Cr	3.4Cr	-86.73L	-90.02L
Net Debt Issued / Repaid	-16.16L	-28.65L	-31.34L	2.37Cr	2.14Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-19.77	7.8	-17.59	-44.96	-29.11
Return on Total Capital	-21.28	8.68	-19.98	-51.38	-38.59
Return On Equity %	-34.61	13.86	-32.86	-87.48	-112.03
Return on Common Equity	-34.61	13.86	-32.86	-87.48	-112.03
Margin Analysis
Gross Profit Margin %	-21.78T	60.66	-105.94	-2.16T	-44.03
SG&A Margin	7.99T	14.93	69.49	934.87	48.8
EBITDA Margin %	-30.38T	25.54	-182	-3.16T	-76.17
EBITA Margin %	-30.49T	25.3	-183.2	-3.17T	-77.11
EBIT Margin %	-30.49T	25.3	-183.2	-3.17T	-77.11
Income From Continuing Operations Margin %	-30.55T	24.92	-185.5	-3.13T	-87.85
Net Income Margin %	-30.55T	24.92	-185.5	-3.13T	-87.85
Net Avail. For Common Margin %	-30.55T	24.92	-185.5	-3.13T	-87.85
Normalized Net Income Margin	-19.09T	15.58	-115.94	-1.96T	-54.91
Levered Free Cash Flow Margin	-18.41T	33.54	-169.4	-1.76T	-40.97
Unlevered Free Cash Flow Margin	-18.37T	33.65	-169.1	-1.76T	-34.05
Asset Turnover
Asset Turnover	0	0.49	0.15	0.02	0.6
Fixed Assets Turnover	0.06	32.81	7.47	0.77	11.49
Receivables Turnover (Average Receivables)	-	-	15.69	-	-
Short Term Liquidity
Current Ratio	13.56	6.07	8.31	3.36	0.8
Quick Ratio	13.47	5.95	8.19	3.28	0.77
Operating Cash Flow to Current Liabilities	-4.26	1.85	-4.41	-4.49	-0.66
Days Sales Outstanding (Average Receivables)	-	-	23.26	-	-
Average Days Payable Outstanding	33.8	35.69	32.37	29.21	27.48
Long Term Solvency
Total Debt/Equity	0.84	1.65	1.37	23.81	185.14
Total Debt / Total Capital	0.83	1.63	1.35	19.23	64.93
LT Debt/Equity	0.36	0.89	0.13	21.27	10.83
Long-Term Debt / Total Capital	0.36	0.88	0.13	17.18	3.8
Total Liabilities / Total Assets	6	15.44	10.11	34.64	76.04
EBIT / Interest Expense	-469.02	142.1	-377.11	-904.97	-6.96
EBITDA / Interest Expense	-458.77	150.79	-364.58	-883.29	-6.53
(EBITDA - Capex) / Interest Expense	-460.79	148.87	-374.26	-884.76	-6.55
Total Debt / EBITDA	-0.03	0.12	-0.04	-0.16	-0.88
Net Debt / EBITDA	3.06	-7.09	2.3	0.48	0.09
Total Debt / (EBITDA - Capex)	-0.03	0.12	-0.04	-0.16	-0.88
Net Debt / (EBITDA - Capex)	3.05	-7.18	2.24	0.48	0.09
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-19.35	69.16T	-70.58	-90.71	1.57T
Gross Profit, 1 Yr. Growth %	-7.71	-292.94	-151.39	89.49	-66.06
EBITDA, 1 Yr. Growth %	-3.99	-158.17	-309.66	61.03	-59.77
EBITA, 1 Yr. Growth %	-3.91	-157.42	-313.03	60.79	-59.48
EBIT, 1 Yr. Growth %	-3.91	-157.42	-313.03	60.79	-59.48
Earnings From Cont. Operations, 1 Yr. Growth %	-4.65	-156.5	-319.01	56.82	-53.26
Net Income, 1 Yr. Growth %	-4.65	-156.5	-319.01	56.82	-53.26
Normalized Net Income, 1 Yr. Growth %	-3.98	-156.5	-319.01	56.82	-53.26
Diluted EPS Before Extra, 1 Yr. Growth %	-18.82	-152.02	-318.8	56.71	-53.27
Accounts Receivable, 1 Yr. Growth %	-	-	-25.68	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	-27.07	93.4	-4.06	-16.7	46.78
Total Assets, 1 Yr. Growth %	77.86	27.67	-31.52	-45.26	-23.1
Tangible Book Value, 1 Yr. Growth %	165.5	34.04	-31.68	-71.76	-120.65
Common Equity, 1 Yr. Growth %	91.32	14.83	-27.2	-60.2	-71.81
Cash From Operations, 1 Yr. Growth %	-2.18	-244.19	-210.86	15.59	-60.21
Capital Expenditures, 1 Yr. Growth %	187.59	79.7	306.21	-89.81	-32.08
Levered Free Cash Flow, 1 Yr. Growth %	6.86	-226.02	-248.61	-3.46	-61.23
Unlevered Free Cash Flow, 1 Yr. Growth %	6.98	-226.71	-247.85	-3.41	-67.74
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	23.72	2.26T	1.33T	-83.47	24.41
Gross Profit, 2 Yr. CAGR %	9.92	33.44	-0.43	-1.32	-19.8
EBITDA, 2 Yr. CAGR %	11.86	-25.22	10.44	83.74	-19.52
EBITA, 2 Yr. CAGR %	11.81	-25.68	10.6	85.08	-19.29
EBIT, 2 Yr. CAGR %	11.81	-25.68	10.6	85.08	-19.29
Earnings From Cont. Operations, 2 Yr. CAGR %	11.22	-26.6	11.24	85.32	-14.38
Net Income, 2 Yr. CAGR %	11.22	-26.6	11.24	85.32	-14.38
Normalized Net Income, 2 Yr. CAGR %	11.78	-26.35	11.24	85.32	-14.38
Diluted EPS Before Extra, 2 Yr. CAGR %	-0.4	-35.01	6.69	85.17	-14.41
Accounts Receivable, 2 Yr. CAGR %	-	-	-	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	89.91	18.77	36.22	-10.61	10.57
Total Assets, 2 Yr. CAGR %	28.27	50.69	-6.5	-38.77	-35.12
Tangible Book Value, 2 Yr. CAGR %	43.01	88.65	-4.3	-56.07	-75.85
Common Equity, 2 Yr. CAGR %	27.96	48.22	-8.57	-46.17	-66.5
Cash From Operations, 2 Yr. CAGR %	12.26	18.77	26.43	13.2	-32.18
Capital Expenditures, 2 Yr. CAGR %	-38.8	127.33	170.18	-35.67	-73.7
Levered Free Cash Flow, 2 Yr. CAGR %	11.62	16.11	36.85	19.78	-38.82
Unlevered Free Cash Flow, 2 Yr. CAGR %	11.66	16.5	36.88	19.51	-44.17
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	40.14	919.65	447.75	166.5	-23.06
Gross Profit, 3 Yr. CAGR %	17.65	32.59	-2.92	23.39	-30.86
EBITDA, 3 Yr. CAGR %	18.38	-10.01	5.44	25.23	10.74
EBITA, 3 Yr. CAGR %	18.27	-10.43	5.57	25.29	11.54
EBIT, 3 Yr. CAGR %	18.27	-10.43	5.57	25.29	11.54
Earnings From Cont. Operations, 3 Yr. CAGR %	17.69	-11.26	5.67	24.73	17.09
Net Income, 3 Yr. CAGR %	17.69	-11.26	5.67	24.73	17.09
Normalized Net Income, 3 Yr. CAGR %	16.96	-10.96	5.91	24.73	17.09
Diluted EPS Before Extra, 3 Yr. CAGR %	4.9	-19.79	-2.6	21.27	17.03
Net Property, Plant and Equip., 3 Yr. CAGR %	108.25	91.06	10.61	15.62	5.46
Total Assets, 3 Yr. CAGR %	31.44	28.07	15.86	-21.78	-33.94
Tangible Book Value, 3 Yr. CAGR %	54.65	39.96	34.47	-36.29	-65.85
Common Equity, 3 Yr. CAGR %	30.93	23.42	16.95	-30.7	-56.61
Cash From Operations, 3 Yr. CAGR %	15.61	22.03	16.07	22.71	-20.11
Capital Expenditures, 3 Yr. CAGR %	21.07	-12.37	175.86	-9.4	-34.5
Levered Free Cash Flow, 3 Yr. CAGR %	13.69	16.27	26.07	21.82	-17.76
Unlevered Free Cash Flow, 3 Yr. CAGR %	14.9	16.51	26.13	21.86	-22.76
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-36.39	131.46	254.63	96.06	202.76
Gross Profit, 5 Yr. CAGR %	29.66	31.45	10.05	17.81	-10.06
EBITDA, 5 Yr. CAGR %	27.25	3.02	15.16	19.73	-5.36
EBITA, 5 Yr. CAGR %	27.06	2.68	15.17	19.74	-5.18
EBIT, 5 Yr. CAGR %	27.06	2.68	15.17	19.74	-5.18
Earnings From Cont. Operations, 5 Yr. CAGR %	34.55	3.93	15.06	19.14	-2.86
Net Income, 5 Yr. CAGR %	50.46	3.93	15.06	19.14	-2.86
Normalized Net Income, 5 Yr. CAGR %	46.76	2.36	14.63	19.38	-2.73
Diluted EPS Before Extra, 5 Yr. CAGR %	9.7	-10.64	5.61	12.09	-7.51
Accounts Receivable, 5 Yr. CAGR %	-	-	180.89	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	41.99	66.68	75.73	41	10.59
Total Assets, 5 Yr. CAGR %	29.63	33.1	14.7	-4.67	-8.12
Tangible Book Value, 5 Yr. CAGR %	96.67	76.38	27.63	-11.96	-32.34
Common Equity, 5 Yr. CAGR %	30.47	30.91	13.41	-11.44	-29.07
Cash From Operations, 5 Yr. CAGR %	26.4	25.81	19.82	18.42	-6.38
Capital Expenditures, 5 Yr. CAGR %	-	26.45	66.91	-22.56	7.75
Levered Free Cash Flow, 5 Yr. CAGR %	26.13	21.83	22.47	17.66	-5.59
Unlevered Free Cash Flow, 5 Yr. CAGR %	26.2	21.92	23.26	17.7	-8.96